Abstract
One potential mechanism for the effectiveness of organoselenium compounds against a number of cancer cell lines is the interaction of selenium with zinc signaling processes. Reducible selenium (rSe) compounds such as diselenides, selenenyl halides and seleninic acids release zinc from zinc fingers and metallothionein. Based upon a review of the literature, two key mechanisms are discussed: the stoichiometric displacement of zinc by selenium and the catalytic oxidation of Cys thiolates by reducible organoselenium compounds produced in situ. Initial DFT calculations of the strengths of interactions between rSe and a Cys2His2-type ZF model are presented to contrast the reactivity of reducible selenium compounds with sulfur and tellurium analogues.
Keywords: Selenium, zinc finger proteins, zinc signaling, cancer prevention, density-functional theory, molecular modeling
Current Chemical Biology
Title:Oxidation of Zinc-Sulfur Centers by Reducible Organoselenium Compounds: A Review and Bonding Perspective
Volume: 7 Issue: 1
Author(s): Craig A. Bayse, Sean M. Whitty and Sonia Antony
Affiliation:
Keywords: Selenium, zinc finger proteins, zinc signaling, cancer prevention, density-functional theory, molecular modeling
Abstract: One potential mechanism for the effectiveness of organoselenium compounds against a number of cancer cell lines is the interaction of selenium with zinc signaling processes. Reducible selenium (rSe) compounds such as diselenides, selenenyl halides and seleninic acids release zinc from zinc fingers and metallothionein. Based upon a review of the literature, two key mechanisms are discussed: the stoichiometric displacement of zinc by selenium and the catalytic oxidation of Cys thiolates by reducible organoselenium compounds produced in situ. Initial DFT calculations of the strengths of interactions between rSe and a Cys2His2-type ZF model are presented to contrast the reactivity of reducible selenium compounds with sulfur and tellurium analogues.
Export Options
About this article
Cite this article as:
A. Bayse Craig, M. Whitty Sean and Antony Sonia, Oxidation of Zinc-Sulfur Centers by Reducible Organoselenium Compounds: A Review and Bonding Perspective, Current Chemical Biology 2013; 7 (1) . https://dx.doi.org/10.2174/2212796811307010006
DOI https://dx.doi.org/10.2174/2212796811307010006 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-Inflammatory Agents from Plants: Progress and Potential
Current Medicinal Chemistry Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation
Recent Patents on Anti-Cancer Drug Discovery Free Flap Head and Neck Reconstruction After Cancer Therapy: Current State of the Art
Current Cancer Therapy Reviews Click Synthesis, Anticancer Activity and Molecular Docking Studies on Pyridazinone Scaffolds
Current Organic Chemistry Design, Synthesis and In vitro Evaluation of Piperazine Incorporated Novel Anticancer Agents
Letters in Drug Design & Discovery Editorial (Thematic Issue: Revisiting the Revolution: Examining the Evolving Role of Antiangiogenic Therapy in Cancer)
Current Drug Targets Hepcidin: Biological Activity, Analytical Methods in Biological Fluids, Clinical Applications and Antagonists. A Short Review
Current Pharmaceutical Analysis Small Molecule Drugs and Targeted Therapy for Melanoma: Current Strategies and Future Directions
Current Medicinal Chemistry TFF (Trefoil Factor Family) Peptides and their Potential Roles for Differentiation Processes During Airway Remodeling
Current Medicinal Chemistry New Treatment Approaches in Acute Myeloid Leukemia: Review of Recent Clinical Studies
Reviews on Recent Clinical Trials Effect of Pinocembrin Isolated from Boesenbergia pandurata on Xenobiotic-Metabolizing Enzymes in Rat Liver
Drug Metabolism Letters Medicinal Chemistry of Adenosine A3 Receptor Ligands
Current Topics in Medicinal Chemistry Lipoamino Acids as Major Components of Absorption Promoters in Drug Delivery
Current Topics in Medicinal Chemistry Nutrition as a Health Determinant in Elderly Patients
Current Medicinal Chemistry Update on the Use of Biologics in Vasculitides
Current Pharmaceutical Biotechnology Post-Translational Modifications of PTEN and their Potential Therapeutic Implications
Current Cancer Drug Targets Editorial: [Hot Topic: TGF-β1 in Pre-Malignant and Malignant Liver Disease]
Current Pharmaceutical Design Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System
Current Cancer Drug Targets Advancing Drug Therapy for Brain Tumours: A Current Review of the Pro-inflammatory Peptide Substance P and its Antagonists as Anti-cancer Agents
Recent Patents on CNS Drug Discovery (Discontinued) Promoting Inter-/Intra- Cellular Process of Nanomedicine through its Physicochemical Properties Optimization
Current Drug Metabolism